Pharmaceutical Published Insights

Published Date : 07 Aug, 2026

The North America bio-identical hormones market is estimated to be valued at USD 1,492.6 Mn in 2026 and is expected to reach USD 2,323.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.5%... View more

Published Date : 07 Aug, 2026

The Europe, ASEAN, Middle East & Africa nutraceuticals market is estimated to be valued at USD 4,999.2 Mn in 2026 and is expected to reach USD 9,592.5 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of... View more

Published Date : 05 Aug, 2026

The HIV-Associated Lipodystrophy Treatment Market is estimated to be valued at USD 199.2 Mn in 2026 and is expected to reach approximately USD 263.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.0% ... View more

Published Date : 05 Aug, 2026

The Antibiotic Bone Cement And Casting Materials Market is anticipated to grow at a CAGR of 8.2% with USD 3.4 Bn in 2026 and is expected to reach USD 6.8 Bn in 2033. Healthcare providers are increasingly adopting adva... View more

Published Date : 04 Aug, 2026

The Global Taurine Market is estimated to be valued at USD 443.8 Mn in 2026 and is expected to reach USD 694.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.60% from 2026 to 2033. This steady growth... View more

Published Date : 04 Aug, 2026

The global lidocaine patches market is estimated to be valued at USD 2,727.6 Mn in 2026 and is expected to reach USD 4,955.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033. Lidoc... View more

Published Date : 03 Aug, 2026

The trigeminal neuralgia treatment market is estimated to be valued at USD 264.7 Mn in 2026 and is expected to reach USD 368.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.23% from 2026 to 2033. Th... View more

Published Date : 03 Aug, 2026

The Large Volume Parenteral Market is estimated to be valued at USD 9.25 Bn in 2026 and is expected to reach USD 12.89 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033. The market ... View more

Published Date : 31 Jul, 2026

The Dedifferentiated Liposarcoma Treatment Market is estimated to be valued at USD 2.0 Bn in 2026 and is expected to reach USD 2.8 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.6% f... View more

Published Date : 31 Jul, 2026

The Measles, Mumps and Rubella (MMR) Vaccines Market is anticipated to grow at a CAGR of 6.1% with USD 4.2 Bn in 2026 and is expected to reach USD 5.8 Bn in 2033. Governments and healthcare organizations are driving t... View more

Published Date : 31 Jul, 2026

The U.S. and Europe clinical nutrition market is estimated to be valued at USD 9,830.9 Mn in 2026 and is expected to reach USD 15,290.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.5%... View more

Published Date : 30 Jul, 2026

The Osteonecrosis Treatment Market is anticipated to grow at a CAGR of 7.2% with USD 276.9 Bn in 2026 and is expected to reach USD 490.7 Bn in 2033. Healthcare providers are driving the growth of the Osteonecrosis Tre... View more

Published Date : 29 Jul, 2026

The acute invasive aspergillosis treatment market is estimated to be valued at USD 4.53 Bn in 2026 and is expected to reach USD 6.50 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.27% from 2026 to 20... View more

Published Date : 28 Jul, 2026

The Thrombocytopenia Treatment Market is anticipated to grow at a CAGR of 4.8% with USD 6.9 Bn share in 2026 and is expected to reach USD 9.3 Bn in 2033. The Thrombocytopenia Treatment Market focuses on therapies and ... View more

Published Date : 28 Jul, 2026

The Stroke Management Market is anticipated to grow at a CAGR of 7.1% with USD 47.2 Bn in 2026 and is expected to reach USD 76.2 Bn in 2033. The Stroke Management Market focuses on products, therapies, and technologie... View more

Published Date : 28 Jul, 2026

The Asia Pacific imiglucerase market is estimated to be valued at USD 192.7 Mn in 2026 and is expected to reach USD 262.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.5% from 2026 ... View more

Published Date : 24 Jul, 2026

Acute Lymphoblastic Leukemia Therapeutics Market is estimated to be valued at USD 4.0 Bn in 2026 and is expected to reach USD 6.9 Bn by 2033, growing at a CAGR of 8.0% from 2026 to 2033. The market is projected to wit... View more

Published Date : 24 Jul, 2026

The Global Secondary Hyperparathyroidism Treatment Market is estimated to be valued at USD 5.13 Bn in 2026 and is expected to reach approximately USD 8.14 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8%... View more